Skip to main content
. 2022 May 4;9:875327. doi: 10.3389/fcvm.2022.875327

FIGURE 7.

FIGURE 7

Forest plot displaying the effects of SGLT2 inhibitors vs. placebo for cardiovascular death in HFpEF patients.